Shanghai Quanjing Medical Imaging Technology Co., Ltd. is described in the articles as China’s largest independent third‑party medical imaging center enterprise. The company is focused on medical imaging centers and related diagnostic imaging operations. Quanjing recently completed a Series B equity financing of more than RMB 600 million. The financing round was jointly led by Cathay Capital (中法凯辉基金), Yuanxing Capital (源星资本) and Yikai Future Industry Fund (易凯未来产业基金). Follow-on participants included TEDA Group (泰达集团), Su Min Tou Junxin Capital (苏民投君信资本) and existing investor Haida Venture Capital (海达创投). Yikai Capital served as the exclusive financial adviser to the transaction.

Total raised

$84M

Funding rounds

1

Latest round

Series B

Latest activity

Jan 2024